Please use this identifier to cite or link to this item:
https://ninho.inca.gov.br/jspui/handle/123456789/3816Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Instituto Nacional de Câncer José Alencar Gomes da Silva | - |
| dc.contributor.author | Instituto Nacional de Câncer (Brasil) | - |
| dc.contributor.author | INCA | - |
| dc.contributor.author | Sistema Único de Saúde (Brasil) | - |
| dc.contributor.author | Brasil. Ministério da Saúde | - |
| dc.date.accessioned | 2021-08-31T17:30:50Z | - |
| dc.date.available | 2021-08-31T17:30:50Z | - |
| dc.date.issued | 2021-06 | - |
| dc.identifier.uri | http://sr-vmlxaph03:8080/jspui/handle/123456789/3816 | - |
| dc.description | 2 p. | - |
| dc.language.iso | other | pt_BR |
| dc.publisher | INCA | pt_BR |
| dc.relation.ispartofseries | Ano V, n. 49. | - |
| dc.subject | Mieloma Múltiplo | pt_BR |
| dc.subject | Quimioterapia | pt_BR |
| dc.subject | Tratamento Farmacológico | - |
| dc.subject | Drug Therapy | - |
| dc.subject | Multiple Myeloma | - |
| dc.subject | Mieloma Múltiple | - |
| dc.title | Quimioterapia do mieloma múltiplo | pt_BR |
| dc.Type | Revistas/Boletins | pt_BR |
| Appears in Collections: | Informe SUS - ONCO 2021 | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| informe-sus-onco-junho-2021.pdf | 482.59 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
